GAMMA Investing LLC Increases Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

GAMMA Investing LLC lifted its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 10,307.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 130,930 shares of the company's stock after purchasing an additional 129,672 shares during the period. GAMMA Investing LLC owned 0.72% of Addus HomeCare worth $12,948,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Natixis raised its stake in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the period. Parkside Financial Bank & Trust raised its stake in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares during the period. Meeder Asset Management Inc. bought a new stake in Addus HomeCare in the 4th quarter valued at $77,000. Finally, Harvest Fund Management Co. Ltd bought a new stake in Addus HomeCare in the 4th quarter valued at $86,000. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Trading Up 0.9%

Addus HomeCare stock traded up $0.97 during trading on Friday, hitting $113.13. 99,535 shares of the company were exchanged, compared to its average volume of 169,534. The business's 50 day moving average is $105.90 and its 200 day moving average is $112.39. Addus HomeCare Co. has a 52 week low of $88.96 and a 52 week high of $136.72. The company has a market capitalization of $2.08 billion, a P/E ratio of 25.89, a PEG ratio of 1.41 and a beta of 0.81.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same quarter in the prior year, the company posted $1.21 earnings per share. Addus HomeCare's revenue was up 20.3% compared to the same quarter last year. Equities analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of research analyst reports. Wall Street Zen cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Macquarie increased their price target on Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Finally, Stephens reaffirmed an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $142.57.

Insider Buying and Selling

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the transaction, the executive vice president now directly owns 7,796 shares of the company's stock, valued at approximately $896,540. This trade represents a 20.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 4.60% of the stock is currently owned by insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.